![Christopher Simms](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Simms
Corporate Officer/Principal chez
4D MOLECULAR THERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
Christopher Simms is Chief Commercial & Business Officer at 4D Molecular Therapeutics, Inc. starting in 2025.
Formerly, Mr. Simms was Chief Commercial Officer & Senior Vice President at IVERIC bio, Inc. Education includes an MBA from York University and an undergraduate degree from Memorial University of Newfoundland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Christopher Simms
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 25/09/2024 |
Anciens postes connus de Christopher Simms
| Sociétés | Poste | Fin |
|---|---|---|
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Formation de Christopher Simms
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial University of Newfoundland
 Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
